tiprankstipranks
CVS Bay Area Inc. (JP:2687)
:2687
Japanese Market
Want to see JP:2687 full AI Analyst Report?

CVS Bay Area Inc. (2687) AI Stock Analysis

0 Followers

Top Page

JP:2687

CVS Bay Area Inc.

(2687)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 5.2)
Rating:50Neutral
Price Target:
¥500.00
▼(-1.19% Downside)
Action:Reiterated
Date:08/04/26
The score is held back primarily by financial risk: elevated leverage, weakened equity in 2026, and persistently negative free cash flow alongside a sharp 2026 net loss. Technical indicators are moderately supportive with a positive trend and momentum, while valuation is mixed—an attractive dividend yield is offset by loss-driven negative P/E.
Positive Factors
Revenue Recovery
A clear multi-year revenue rebound through 2024–2026 indicates recovering demand and improved market traction versus the 2021–2023 downturn. Sustained top-line growth supports scale benefits, improves operating leverage potential, and underpins longer-term profitability if the trend continues.
Negative Factors
Elevated Leverage
A higher debt load with declining equity tightens financial flexibility and raises refinancing and covenant risks. Elevated leverage limits the company's ability to invest or absorb shocks, increases interest expense sensitivity, and constrains strategic options over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Recovery
A clear multi-year revenue rebound through 2024–2026 indicates recovering demand and improved market traction versus the 2021–2023 downturn. Sustained top-line growth supports scale benefits, improves operating leverage potential, and underpins longer-term profitability if the trend continues.
Read all positive factors

CVS Bay Area Inc. (2687) vs. iShares MSCI Japan ETF (EWJ)

CVS Bay Area Inc. Business Overview & Revenue Model

Company Description
CVS Bay Area Inc., established in 1981 and based in Chiba, Japan, engages in a variety of business ventures. The company manages seven convenience stores operating under the Lawson brand across Japan, alongside eight hotels bearing the BAY HOTEL n...
How the Company Makes Money
null...

CVS Bay Area Inc. Financial Statement Overview

Summary
Revenue and operating profitability improved versus the 2021–2023 downturn, but 2026 saw a sharp net loss despite positive EBIT/EBITDA, signaling earnings volatility. Leverage is elevated and equity weakened in 2026, while consistently negative free cash flow is the largest risk, reducing self-funding capacity.
Income Statement
46
Neutral
Balance Sheet
52
Neutral
Cash Flow
34
Negative
BreakdownTTMFeb 2026Feb 2025Feb 2024Feb 2023Feb 2022
Income Statement
Total Revenue7.89B7.90B7.82B7.52B6.93B7.21B
Gross Profit3.59B3.50B3.49B3.23B2.57B2.12B
EBITDA476.40M439.35M572.44M643.26M238.81M-160.49M
Net Income-1.10B-1.14B1.12B697.62M-13.53M-831.52M
Balance Sheet
Total Assets10.40B10.37B11.27B10.31B8.68B9.41B
Cash, Cash Equivalents and Short-Term Investments1.85B1.89B1.78B1.89B1.77B1.73B
Total Debt5.68B5.72B5.29B5.32B4.48B4.85B
Total Liabilities7.23B7.24B6.89B6.95B5.94B6.58B
Stockholders Equity3.17B3.13B4.38B3.36B2.74B2.83B
Cash Flow
Free Cash Flow0.00-177.40M-1.08B-635.20M-196.02M-406.11M
Operating Cash Flow0.00315.26M410.52M481.89M-172.53M-351.39M
Investing Cash Flow0.00-525.70M-384.36M-1.08B654.76M232.76M
Financing Cash Flow0.00314.97M-129.65M710.97M-442.98M-84.74M

CVS Bay Area Inc. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price506.00
Price Trends
50DMA
484.72
Positive
100DMA
490.06
Positive
200DMA
502.03
Negative
Market Momentum
MACD
4.70
Negative
RSI
66.83
Neutral
STOCH
86.74
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2687, the sentiment is Positive. The current price of 506 is above the 20-day moving average (MA) of 495.15, above the 50-day MA of 484.72, and above the 200-day MA of 502.03, indicating a neutral trend. The MACD of 4.70 indicates Negative momentum. The RSI at 66.83 is Neutral, neither overbought nor oversold. The STOCH value of 86.74 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2687.

CVS Bay Area Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
¥69.76B11.610.70%8.19%4.99%
71
Outperform
¥104.22B10.582.59%0.95%3.40%
68
Neutral
¥31.95B24.532.22%19.03%-8.79%
67
Neutral
¥223.56B17.432.62%3.25%1.50%
66
Neutral
¥64.21B13.892.85%6.89%-10.99%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
50
Neutral
¥2.46B-2.244.73%-0.21%-208.17%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2687
CVS Bay Area Inc.
502.00
-86.97
-14.77%
JP:3539
JM Holdings Co., Ltd.
1,378.00
-116.40
-7.79%
JP:7508
G-7 Holdings Inc.
1,408.00
145.37
11.51%
JP:7596
Uoriki Co., Ltd.
2,294.00
-147.05
-6.02%
JP:8194
Life Corporation
2,623.00
130.06
5.22%
JP:8198
Maxvalu Tokai Co., Ltd.
3,170.00
12.54
0.40%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 04, 2026